United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2003_register
executive
2010-09-23
article
Minimizing Medication Errors-Methods for Evaluating Proprietary Names for Their Confusion Potential; Public Meeting; Correction
Notices
D09002ee1bdebf052
D09002ee1bdebf0e7
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of May 30, 2003 (68 FR 32529). The document announced a public meeting to explore current methods being used to evaluate proprietary drug names to reduce medication errors due to similarity in drug names. The document published with inadvertent errors. This document corrects those errors.
68 FR 35679
https://www.govinfo.gov/app/details/FR-2003-06-16/03-15058
03-15058
fr16jn03-71
4160-01-S
Docket No. 02N-0201
https://www.govinfo.gov/app/details/FR-2003-06-16/03-15058
https://www.govinfo.gov/content/pkg/FR-2003-06-16/html/03-15058.htm
https://www.govinfo.gov/content/pkg/FR-2003-06-16/pdf/03-15058.pdf
1 p.
35679
35679
68 FR 35679
Minimizing Medication Errors-Methods for Evaluating Proprietary Names for Their Confusion Potential; Public Meeting; Correction; Federal Register Vol. 68, Issue
NOTICE
03-15058
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Docket No. 02N-0201
4160-01-S
03-15058
Notice of public meeting; correction.
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of May 30, 2003 (68 FR 32529). The document announced a public meeting to explore current methods being used to evaluate proprietary drug names to reduce medication errors due to similarity in drug names. The document published with inadvertent errors. This document corrects those errors.
Joyce Strong, Office of Policy and Planning (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.
Meetings:
Drugs; proprietary names evaluation for confusion potential; minimizing medication errors; correction,
Federal Register
Vol. 68, no. 115
Office of the Federal Register, National Archives and Records Administration
2003-06-16
continuing
daily
deposited
born digital
271 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2003-06-16
P0b002ee1809caac2
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr16jn03
https://www.govinfo.gov/app/details/FR-2003-06-16
https://www.govinfo.gov/content/pkg/FR-2003-06-16/pdf/FR-2003-06-16.pdf
https://www.govinfo.gov/content/pkg/FR-2003-06-16/xml/FR-2003-06-16.xml
fdlp
35525
35782
DGPO
2010-09-23
2023-05-04
FR-2003-06-16
machine generated
eng
FR
FR-2003-06-16
68
115